MPX-111

N/A

Report date: 2025/01/26 16:00:39

NME

Base Information

Drug NameMPX-111

Drug Alias Nameinhaled receptor tyrosine kinase inhibitor (Metera Pharmaceuticals)Tyrosine Kinase Inhibitor (Metera)Tyrosine Kinase Inhibitor (RespiVert)MPX-111

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein-tyrosine kinases inhibitors

TargetsProtein-tyrosine kinases

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRespivert Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMetera Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A